The developers of a cannula for minimally-invasive central aortic perfusion—...
CathWorks has announced approval of the fourth generation CathWorks FFRangio...
A global research initiative will compare coronary artery bypass graft surge...
The chance of a patient surviving after an acute type A aortic dissect...
Clinical trials in cardiothoracic surgery must ensure that sufficient number...
Ajay Kirtane (Columbia University Irving Medical Center New York-Presbyteria...
Results of the FLASH registry demonstrate the “excellent safety profile” of ...
Three-year outcomes from the SMART-CHOICE trial have shown that P2Y12 inhibitor ...
ABILITY DIABETES-GLOBAL, a randomised controlled head-to-head trial comparing sa...
Puzzle Medical Devices was announced as the winner of the Shark Tank innovation ...
The use of rivaroxaban for seven days after a transradial coronary procedure...
Results of a new per-protocol analysis of the ST-segment Elevation Myocardia...
OpSens has announced that Philippe Genereux (Morristown Medical Center, Morristo...
Biotronik has announced the presentation of new full-cohort two-year BIOSOLV...
Medtronic has received Food and Drug Administration (FDA) approval for the treat...
JenaValve Technology has announced the successful completion of patient enrolmen...
Analysis of data from the Society of Thoracic Surgeons/American College of C...
Results from a multicentre randomised trial comparing ultrasound with fluoro...
Medtronic has announced the expanded US market release of its newest-generation,...
Shockwave Medical has initiated a prospective coronary intervention study consis...
Advanced NanoTherapies has been granted US Food and Drug Administration (FDA...
Long-term follow-up of patients with non-valvular atrial fibrillation (AF) r...
Findings from the RADIANCE II randomised pivotal trial, presented at the 202...
The major contribution of Valentin Fuster (Mount Sinai Health System, New Yo...
The first randomised trial to compare two transcatheter edge-to-edge repair ...
Among patients undergoing transfemoral transcatheter aortic valve implantati...
OpSens has received 510(k) regulatory clearance from the US Food & Drug Admi...
The 2022 Transcatheter Cardiovascular Therapeutics (TCT, 16–19 September, Bo...
Abiomed has announced two approvals from the US Food and Drug Administration (FD...
Edwards Lifesciences has announced that its Pascal Precision transcatheter valve...
Teleflex has announced that Magnus Settergren, associate professor at the Karoli...
Cardiac Implants has announced the successful initial deployment of its annulopl...
Concept Medical has announced the successful completion of the TRANSFORM 1 R...
A budget impact analysis comparing transcatheter aortic valve implantation (...
Haemonetics Corporation has received CE mark certification for its Vascade v...
Edwards Lifesciences has announced the launch of the Sapien 3 Ultra Resilia valv...
Abbott has announced three-year data for its Amplatzer Piccolo occluder for the ...
Analysis of the global make-up of the four largest global societies for cardioth...
Results of an analysis of Aktiia’s cuffless blood pressure (BP) monitoring syste...
Zoll Medical has announced that the first patient has been enrolled in the AMIHO...
Abbott has announced the European launch of its Amplatzer Talisman patent forame...
AtriAN Medical has announced that it has completed enrolment of a second study u...
As a proponent of minimally invasive cardiac surgery and transcatheter technique...
The most read stories from across Cardiovascular News in August 2022 include hig...
Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for a...
Royal Philips has announced that Baptist Health’s Miami Cardiac & Vascular I...
Boston Scientific has received US Food and Drug Administration (FDA) approva...
Andrew Wigham (Oxford, UK) and Rick De Graaf (Friedrichshafen, Germany) dis...
Cardionovum has announced the enrolment of the first patient in the internat...
JenaValve Technology has announced that it has completed the initial closing of ...
Researchers have developed a risk score to predict mortality for patients wi...
Abbott has announced the release of late-breaking showing that its HeartMate...
Transradial access for percutaneous coronary procedures is associated with l...
Fifteen-month results from the MASTER DAPT trial have shown that the preserv...
In patients with advanced chronic kidney disease (CKD) and chronic coronary ...
Selection of non-infarct related artery (IRA) lesions for intervention using...
Late-breaking research presented at the European Society of Cardiology (ESC)...
Among high-risk patients undergoing percutaneous coronary intervention (PCI)...
Results of one of the first and only randomised, blinded trials to assess th...
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality...
Use of a ‘polypill’ after myocardial infarction (MI)—an all-in-one pill cont...
ŌNŌCOR has announced in a company press release that the ŌNŌ endovascular retrie...
The timing of dosing of antihypertensive medication—whether it is taken in t...
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have ann...
Medtronic has announced the launch of its latest generation drug-eluting coronar...
In this issue:
Call for action over age and gender profile of global cardio...
In this issue:
Call for action over age and gender profile of global cardio...
Miracor Medical has announced the approval of an investigational device exem...
Pi-Cardia has announced a successful first-in-human treatment of the mitral valv...
Edwards Lifesciences has announced that the company's Pascal Precision trans...
Abiomed has announced the results of the Restore EF study, demonstrating that I...
CX Aortic Vienna returns in October for its third edition (24–26 October, Digita...
The American Heart Association (Association) and the Cardiovascular Research Fou...
Ongoing clinical trials looking at transcatheter aortic valve implantation (...
The most read stories from across Cardiovascular News in July 2022 include refle...
Projected rates of cardiovascular risk factors and disease will increase signifi...
Thubrikar Aortic Valve has announced successful 30-day outcomes in the first two...
Cardiac surgeons from North America, Europe and Latin America are among the sign...
A project to develop genetic therapies to effectively cure cardiomyopathy ha...
iVascular has announced the release of three-year observational data concerning ...
Neovasc has announced that the US Food and Drug Administration (FDA) has app...
Centese has announced the publication of the first peer-reviewed clinical study ...
Pi-Cardia has received Investigational Device Exemption (IDE) approval from the ...
ReCor Medical and Otsuka Medical Devices have announced that the RADIANCE II US ...
Incentives for the enrolment of patients from socieconomically disadvantaged...
Cathbot—a joint venture between Robocath and MicroPort—has enrolled the last pat...
Preventing coronary obstruction after transcatheter aortic valve implantatio...
A research project at the University of Leeds (Leeds, UK) aiming to find an ...
Ancora Heart has announced that the US Food and Drug Administration (FDA) ha...
Intratech Medical has announced the successful enrolment of two patients in a mu...
The VenusP-Valve (Venus Medtech) transcatheter pulmonic valve replacement (T...
Medtronic today announced it has entered into a strategic partnership agreement ...
Patients identified by nuclear stress testing as having severe stress-induce...
Transcatheter aortic valve implantation (TAVI) will continue to spread acro...
Echocardiographers may be at significantly greater risk of exposure to radiation...
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announc...
A subgroup analysis of the BIO-RESORT trial has shown a “trend towards bette...
HeartBeam is expanding the available patient population for its emergency depart...
The most read stories from across Cardiovascular News in June 2022 include highl...
Suzanne Baron and Ki Park detail some of the barriers facing women in the fi...
Advanced NanoTherapies has closed a US$7.2 million Series A equity financing...
Results from the first commercial implants of the Trilogy transcatheter aort...
Teleflex has announced the first patient enrolment in a clinical study that ...
People who develop an arrhythmia after surgery have an increased risk of subsequ...
Acutus Medical has announced the commercial launch of an expanded suite of l...
A retrospective study from Kubkin Choi and researchers from Mayo Clinic (Rochest...
SoniVie recently announced that on 5 May 2022 the US Food and Drug Administratio...
Conformal Medical has announced the launch of the CONFORM pivotal trial with...
The National Institute for Health and Care Excellence (NICE) has recommended...
Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO...
Transcatheter aortic valve implantation (TAVI) with the Acurate neo2 (Boston...
Analysis of the EXPAND registry, looking at one-year outcomes of MitraClip t...
Data from the first report on patients with a pacemaker lead across the tric...
AtriCure has announced that the first patient has been treated in the HEAL-IST t...
The potential to utilise artificial intelligence (AI) or machine learning in c...
This advertorial is sponsored by Adept Medical.
Outlining Adept Medical’s pro...
A retrospective review of more than 24,000 patients who underwent an electrocard...
Filterlex Medical has announced results from a first-in-human (FIH) study de...
A study has revealed the “global collateral damage” caused by the disruption to ...
A new consensus statement—in development from the European Society of Cardi...
“At the moment, tricuspid is the valve where most things are happening,” sa...
Transcatheter aortic valve implantation (TAVI) was found to be non-inferior ...
The use of distal radial artery access for percutaneous coronary interventio...
Concurrent tricuspid valve surgery and left ventricular assist device (LVAD)...
Robotic-assisted percutaneous coronary intervention (PCI) has the potential...
New data confirming one-year outcomes with coronary intravascular lithotrips...
Sunil Rao (Duke University Health System, Durham, USA) has assumed the offic...
Endotronix has announced data from the SIRONA 2 clinical trial evaluating sa...
Shockwave Medical and Genesis MedTech Group announced today that they have succe...
Adept Medical says it has responded to the call from interventional radiolog...
Transcatheter tricuspid valve repair potentially offers a “less risky” opti...
One-year outcomes of the CLASP TR study, investigating the use of the Pascal (Ed...
Matti Adam (Cologne, Germany) talks to Cardiovascular News about the evolut...
Use of the cusp overlap technique for the deployment of devices in transcath...
Results of the 20-patient, first-in-human clinical study supporting the safety a...
Patients in England with ST-elevation myocardial infarction (STEMI) had an a...
“Renal denervation has travelled a very storied path over the last 10–15 ye...
Analysis of data from a US-wide health system suggests that the volume of percut...
Biotronik has shared new data presented at EuroPCR 2022 (17–20 May, Paris, F...
New data on robotic-assisted percutaneous coronary intervention (PCI) have been ...
Vivasure Medical has announced the closing of the first tranche of €22 million (...
Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR...
Late-breaking trial data presented at EuroPCR 2022 (17–20 May, Paris, France...
Medtronic has announced that it has received US Food and Drug Administration (FD...
In this issue:
New data hint at positive performance of TAVI on structural ...
In this issue:
New data hint at positive performance of TAVI on structural ...
A US analysis comparing trends in transcatheter and surgical mitral valve repair...
Abbott has announced a new partnership with Women as One to launch a new program...
Vijay Kunadian (Newcastle University and Newcastle upon Tyne Hospital NHS Founda...
This advertorial is sponsored by Siemens Healthineers
In the modern cath lab,...
This advertorial is sponsored by Medtronic
Due to the growth of transcath...
The most read stories from across Cardiovascular News in April 2022 include high...
At the 2022 Charing Cross (CX) International Symposium (26–28 April, London,...
This educational supplement, sponsored by Medtronic, explores the science underp...
In the history of transcatheter aortic valve implantation (TAVI), 16 April 2002 ...
OpSens has announced that it has received Health Canada approval for the SavvyWi...
Biosensors International Group has announced both the Japanese Pharmaceutica...
Medtronic has announced the first patient enrolment in the EXPAND TAVR II pi...
Medtronic has announced that Laura Mauri has been appointed as the company’s chi...
The Society for Cardiovascular Angiography & Interventions (SCAI) has releas...
Translumina has announced the launch of Vivo Isar, its latest generation dual dr...
The pandemic saw a boom in the use of remote technologies and telehealth for...
Corindus, a Siemens Healthineers company, announced today the opening of its new...
Transit Scientific has announced US Food and Drug Administration (FDA) clear...
Quest International and CathWorks have announced a strategic partnership. Qu...
Viz.ai has raised a US$100 million funding round at a US$1.2 billion valuation, ...
Venus Medtech's transcatheter pulmonic valve replacement (TPVR) system—Venus...
CeloNova BioSciences has announced the strategic decision to focus its core ...
Patients treated with edoxaban for six months after a transcatheter aortic v...
The most read stories from across Cardiovascular News in March 2022 include a we...
FEops has announced that it received authorisation from the US Food and Drug...
Abiomed has announced that the first patient in Japan has been treated succe...
Biosensors International has announced the enrolment of the first patient in the...
Patients who received a transcatheter supra-annular self-expanding heart valve h...
Latest results from the North American COVID-19 STEMI (NACMI) registry repor...
A head-to-head comparison of fractional flow reserve (FFR) and intravascular ult...
Long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial have be...
Patients with tricuspid regurgitation (TR) who received a Pascal transcatheter v...
Corvia Medical has announced publication of analyses from its global, phase ...
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (...
East End Medical has announced the first commercial use of its SafeCross tra...
Royal Philips is launching an echocardiography image analysis and reporting solu...
The Society for Cardiovascular Angiography & Interventions (SCAI) has releas...
Edwards Lifesciences has announced it received approval from the US Food and Dru...
Shockwave Medical’s C2 coronary intravascular lithotripsy (IVL) catheter has rec...
Miracor Medical has announced the first patient enrolled in the PICSO-AMI-V ...
Investigators have completed enrolment in the RADIANCE-II pivotal trial of the P...
Carmat, designer and developer of an advanced total artificial heart, has is...
Researchers have detailed the use of an artificial intelligence-enabled tool...
Cardiawave has announced the success of its first-in-human I (FIH I) safety and ...
A consensus document outlining design principles and outcome definitions for dev...
Four radial cases using the PH Band System (Medical Ingenuities)—a novel med...
Venus Medtech has appointed Shakeel Osman as senior vice president of sales Euro...
Women are less likely to receive lifesaving treatment for cardiogenic shock than...
Only 76% of heart attack patients with dyspnoea or fatigue as their main symptom...
Nick West, chief medical officer and divisional vice president of Global Med...
Xeltis has announced promising initial outcomes from two key vascular trials inv...
The American College of Cardiology (ACC) has issued an expert consensus decision...
Cardiovascular Systems—CSI—has announced the first in-human experience with Prop...
Vivasure Medical has announced today that the first patient was treated in a...
A new strategy using telehealth to monitor blood pressure at home for severa...
“When I was one year old, my father died in the war between Israel and Egypt...
Big Sky Biomedical has appointed Ryan Egeland as managing director.
“Big ...
Medtronic has announced that it has entered into a contract with Vizient to ...
The most read stories from across Cardiovascular News in February 2022 include t...
Two-year findings from the Low-risk TAVI (LRT) Trial, assessing clinical out...
A novel transcatheter system designed for transfemoral mitral valve repair—t...
Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual ...
Four-year data from the LRT—Low Risk TAVR—trial show that transcatheter aort...
Levels of high-sensitivity troponin I after cardiac surgery that were associated...
Biotronik has announced final enrolment in the BIOMAG-I clinical trial by Mi...
Results from a new analysis assessing real-world outcomes with the Watchman ...
Women remain underrepresented in leading cardiovascular clinical trials, cor...
Results from the first animal study of the Tria transcatheter aortic valve (...
Final five-year results from the BIOFLOW-V trial, presented during a late-br...
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to thi...
Wearable technology and digital health specialist Activinsights has announced a ...
Patients with both a high lipoprotein(a) and high coronary artery calcium sc...
Anticipation is building for the Charing Cross International Symposium 2022 ...
Teleflex has announced that the US Food and Drug Administration (FDA) has cleare...
Historically, catheter ablation has been reserved for atrial fibrillation (A...
Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated...
Siemens Healthineers has announced the launch of Artis icono biplane—an angiogra...
The “Ross procedure” may be a more favourable option for aortic valve replac...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
A 10-year study monitoring patients receiving “on-pump” or “off-pump” coronary a...
Consultation by a heart team led to an observed benefit in objective patient out...
Researchers have developed a novel method of measuring growth of thoracic aortic...
Cardiologist and researcher Robert Califf has been confirmed as the commissi...
Robotic systems have the potential to fundamentally change the way care is deliv...
The donation of new 3D printing technology to the Visible Heart Laboratories...
Elixir Medical has announced completion of enrolment in the BIOADAPTOR rando...
Boston Scientific has announced the close of its acquisition of Baylis Medic...
MedHub has announced the completion of a funding round worth US$1 million in new...
The Supreme healing-targeted drug-eluting stent (Sinomed) is effective and s...
Peter Haworth (Portsmouth Hospitals University NHS Trust, Portsmouth, UK) docume...
HeartFlow has announced that it and Longview Acquisition Corporation have mutual...
Lung cancer patients with higher amounts of coronary artery calcium have an incr...
The use of intravascular ultrasound (IVUS) guidance for implantation of drug-elu...
The most read stories from across Cardiovascular News in January 2022 include co...
Acarix has submitted a breakthrough designation request for its technology for h...
The John Radcliffe Hospital—part of Oxford University Hospitals NHS Foundati...
Royal Philips has announced an update to its handheld ultrasound platform—Lumify...
Atheart Medical has announced that it has received US Food and Drug Administ...
The placement of an interarterial shunt device—the Corvia atrial shunt (Corv...
Biosensors has announced the enrolment of the first patient in the RISE SC study...
BioCardia has announced that the US Food and Drug Administration (FDA) has grant...
CroíValve has raised a Series A round to fund a feasibility clinical study w...
Black adults born in the USA had a higher rate of death from cardiovascular ...
The Society for Cardiovascular Angiography & Interventions (SCAI) has an...
Abbott has released a second round of insights from its Beyond Intervention ...
This advertorial is sponsored by Shockwave Medical.
The latest data from the ...
This advertorial is sponsored by Medtronic.
Evolut PRO+ is the latest generat...
Born in India and raised in Pittsburgh, USA, Susheel Kodali now practices in...
In this issue:
Coronary revascularisation guidelines spark debate
New d...
In this issue:
Coronary revascularisation guidelines spark debate
New d...
Insights from what was described as the “largest and most comprehensive” ana...
Artivion has announced the publication of PROACT clinical trial results in The A...
The Society for Cardiovascular Angiography and Interventions (SCAI) has rele...
Cardiothoracic surgeon John H Calhoon from The University of Texas Health Sc...
Patients with mitral valve disease who live in disadvantaged communities are...
InnovHeart, developer of novel transcatheter mitral valve replacement (TMVR) sys...
Organisers of the Joint Interventional Meeting (JIM) have announced that the 202...
The first patient has been enrolled in the TRANSFORM II randomised controlle...
Radiation exposure during percutaneous coronary intervention (PCI) has fallen “c...
Researchers have warned that the number of people suffering from aortic valve st...
The US Food and Drug Administration (FDA) has issued two final guidances providi...
Congenita has been named a recipient of the MedTech NAVIGATOR Innovation Grant S...
A review evaluating the results of thoracic endovascular aortic repair (TEVA...
New clinical practice guidelines have been published today, and are intended to ...
CytoSorbents has called attention to a new publication which reports on the use ...
Cardiovascular Systems (CSI) and OrbusNeich Medical Company have announced US Fo...
WL Gore & Associates has announced that its Cardioform Septal Occluder h...
In a joint programme between the Society of Thoracic Surgeons (STS) and the ...
A new study reports that watching TV for four hours a day or more is associated ...
Royal Philips today announced physicians will now have access to advanced ne...
New guidelines from the American College of Cardiology (ACC) and the American He...
Cardiovascular Systems recently announced that it has made significant progress ...
A propensity score-matched analysis of the early outcomes of transcatheter aorti...
A 57-year-old patient with terminal heart disease received a successful transpla...
The American Association for Thoracic Surgery (AATS) and The Society of Thoracic...
The Society of Thoracic Surgeons (STS) has moved its 2022 annual meeting from an...
Terumo Medical Corporation has welcomed the publication of updated guidelines fr...
Robocath has announced the conclusion of its R-Evolution clinical study in Europ...
Regulators in three countries have granted approvals to Impella surgical product...
Medtronic has announced that the National Medical Products Administration (N...
The most read stories from December 2021 include analysis of the CHEETAH study a...
Neovasc has announced enrolment of the first patient in the COSIRA-II clinical t...
Endotronix has announced that the US Food and Drug Administration (FDA) has ...
Biomodex and the Montreal Heart Institute (MHI, Montreal, Canada) are partne...
Vesalio recently announced the start of enrolment in its NATURE study using enVa...
Royal Philips has announced US Food and Drug Administration (FDA) de novo cl...
Foldax has announced publication of the first clinical results for its Tria ...
Edwards Lifesciences has received approval from the US Food and Drug Adminis...
Doctors at St David's Medical Center in Austin, USA recently implanted a new neu...
Many patients undergoing cardiac surgery may be able to safely and effectively c...
FAST BioMedical has announced the publication of additional results from the EMP...
Thubrikar Aortic Valve has received approval from a Competent Authority in Polan...
Ultromics has announced the publication of a study assessing its EchoGo plat...
HeartFlow has announced it has submitted a 510(k) premarket application to the U...
Results of the CHEETAH clinical study highlight the potential role of mechan...
Svelte Medical Systems has received US Food and Drug Administration (FDA) approv...
Opsens has filed a 510(k) submission with the US Food & Drug Administration ...
The Society of Thoracic Surgeons (STS) has appointed Joanna Chikwe (chair of the...
The likelihood of patients with suspected or known coronary artery disease dying...
Huge strides have been made in preventing contrast-associated acute kidney i...
New guidelines for coronary artery revascularisation recommend that treatment de...
A team led by investigators at Massachusetts General Hospital (MGH) in Boston, U...
RSIP Vision has announced a new coronary artery modelling technology, which enab...
Royal Philips has announced an expansion of its ultrasound portfolio with ne...
Foldax has announced that the Drugs Controller General of India (DCGI), India’s ...
Venus Medtech has announced its acquisition of Cardiovalve, a transcatheter mitr...
SyMap Medical has announced the completion of a financing round which will b...
Restore Medical has announced preliminary results of the first-in-human clinical...
The first analysis of findings from the bRIGHT registry, detailing rea...
One in 10 junior doctors training to be cardiologists in the UK say they have be...
Interim results from the REVERSE-IT trial of bentracimab (PhaseBio Pharmaceu...
Featuring stories from the Transcatheter Cardiovascular Therapeutics annual meet...
A novel artificial intelligence (AI) algorithm that identifies a cardiac dysfunc...
Soundbite Medical Solutions has announced that the US Patent and Trademark Offic...
Robocath has announced the successful completion of what it has described as the...
Findings of the CHOICE MI registry show that transcatheter mitral valve impl...
Findings from an on-treatment major bleeding analysis from the ENVISAGE TAVI...
Mirvat Alasnag is the Gulf region’s first female interventional cardiologist. Cu...
Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic...
Two-year findings of a post-hoc study from the GALILEO trial, investigating ...
First clinical results of transcatheter aortic valve implantation (TAVI) usi...
The first 30-day results following the implantation of the NeoChord NeXuS tr...
Opsens has announced the successful treatment of 20 patients leading to the comp...
The Minneapolis Heart Institute Foundation (MHIF; Minneapolis, USA) has announce...
The first patients have been enrolled in the FAST III trial at the Erasmus Unive...
European Society of Cardiology (ESC) guidance for the diagnosis and management o...
New guidance on the diagnosis and presentation of cardiogenic shock aims to ...
A meta-analysis comparing percutaneous coronary intervention (PCI) using a d...
Nonagenarians should not be refused transcatheter aortic valve implantation (TAV...
An updated risk score to predict possible contrast-associated acute kidney i...
Use of a novel, venous external support device (VEST, Vascular Graft Solutio...
HeartVista has received US Food and Drug Administration (FDA) 510(k) clearance t...
Coronary artery bypass graft sugery (CABG) between two and three days after tica...
Asymptomatic patients with severe aortic stenosis (AS) may benefit from early ao...
Ahead of the American Heart Association’s 2021 annual scientific sessions (AHA 2...
This advertorial is sponsored by iVascular
Treatment of a chronic total occlu...
Early data presented at the Transcatheter Cardiovascular Therapeutics annual...
Caption Health and Ultromics have announced a strategic partnership to accelerat...
Abbott has released new research from its Beyond Intervention initiative, a mult...
SIS Medical AG has appointed Ron Waksman, associate director Division of Car...
Transcatheter aortic valve implantation (TAVI) pioneer and principal investigato...
Cardiovascular Systems has announced the start of enrolment in a first in-human ...
Patients who went into cardiac arrest in the cardiac cath lab were more likely t...
CoreMedic has announced the publication of two-year follow-up results from the f...
Medtronic has announced its ambition to achieve net zero carbon emissions by fis...
Data from the BIOSOLVE-IV trial, presented at the Transcatheter Cardiovascul...
Six-month results from the TRISCEND study of the Evoque (Edwards Lifescience...
Early data for the self-expanding Intrepid (Medtronic) transcatheter mitral ...
Findings of the SWISS-APERO trial, presented at the Transcatheter Cardiovasc...
Patients receiving antiplatelet therapy following percutaneous coronary inte...
The final results of the PROTECT III and Restore EF prospective studies demo...
Left atrial appendage occlusion (LAAC) remains non-inferior to non vitamin-K...
Five-year clinical and echocardiographic outcome data from the SURTAVI rando...
Results from the largest randomised trial to date comparing different closur...
An economic analysis of data from the PARTNER 3 randomised trial, comparing ...
Penumbra has announced that the CHEETAH clinical study of its Indigo system ...
One-year outcomes from the Disrupt CAD III clinical study of Shockwave intravasc...
Results from SUGAR, a randomised controlled, multicentre trial conducted exclusi...
Randomised placebo-controlled trials show consistently that renal denervation pr...
Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing en...
Lesion selection for percutaneous coronary intervention (PCI) using the non-inva...
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (...
Medtronic has announced findings from a new study of patient preferences for the...
In this issue:
MASTER DAPT game changing for short-duration dual antiplate...
In this issue:
MASTER DAPT game changing for short-duration dual antiplate...
Royal Philips has previewed updates in its product portfolio and new data due to...
Procyrion has announced the presentation of studies at the Transcatheter Cardiov...
Hypertension health-tech firm Aktiia has announced a US$17.5 million Series ...
ReValve Solutions has announced that it has successfully completed the first-in-...
Results from two studies of the Impella heart pump device will be presented at t...
This educational supplement, sponsored by Medtronic, explores the latest evidenc...
Joint clinical practice guidelines have been issued by the American Heart Associ...
Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACT...
The longest available real-world follow-up data of transcatheter mitral ...
Teleflex announced the completion of patient enrolment in a clinical study evalu...
Patients who survive an aortic dissection often fail to receive comprehens...
The Cardiovascular Research Foundation (CRF) has announced that the digital comp...
Sinomed has announced that the PIONEER III clinical trial results for its HT...
Cardiac CT angiography (CTA) derived left atrium emptying fraction (LAEF) im...
JenaValve Technology has announced the first commercial implants with the Trilog...
HeartFlow has announced the commencement of the REVEALPLAQUE trial to evaluate t...
The expansion of transcatheter aortic valve implantation (TAVI) in the USA has p...
Ethnic and racial minority cardiologists report career satisfaction but face pro...
“We are at the beginning of a type A dissection revolution,” Joseph E Bavari...
The underrepresentation of women in clinical coronary revascularisation tria...
OpSens has announced the commencement of the human clinical study utilising the ...
Building and maintaining expertise in both open and endovascular surgical te...
ReCor Medical has announced that its Paradise ultrasound renal denervation syste...
Baylis Medical Company has reached an agreement to sell its cardiology business ...
In a session on “Reduction of radiation challenges” at CX Aortic Vienna 2021...
Bert van Meurs is the chief business leader for Image Guided Therapy within Roya...
A decisive vote at CX Aortic Vienna 2021 (5–7 October, broadcast) revealed t...
Results of a poll conducted at CX Aortic Vienna 2021 (5–7 October, broadcast...
A worldwide committee of 40 cross-specialty medical experts achieved the fir...
NeoChord has announced successful completion of the first-in-human procedure wit...
Top stories for September included more highlights from the European Society of ...
Royal Philips and Lankenau Heart Institute part of Main Line Health (Wynnewood, ...
The US Food and Drug Administration (FDA) has informed healthcare providers of r...
Foldax has announced completion of enrolment in the US early feasibility study o...
Cardiovascular Systems recently announced that the first patient has been succes...
Siemens Healthineers has launched the Luminos Impulse fluoroscopy system, includ...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
Biotronik has announced that it has received US Food and Drug Administration...
Patients awaiting coronary artery bypass grafting (CABG) or percutaneous cor...
Open Stent Solution (OSS) has announced the closing of a €2.5 million Seed finan...
The Heart Rhythm Society (HRS) has announced that its cardiovascular digital hea...
Capturing the latest developments in the comprehensive treatment of aortic disea...
This advertorial is sponsored by Medtronic
As transcatheter aortic valve ...
George Dangas (New York, USA) discusses the results of the TWILIGHT-Stent tri...
Neovasc has announced that it has received Food and Drug Administration (FDA) ap...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
Patients at low surgical risk who had undergone transcatheter aortic valve i...
A cardiothoracic surgical team with UofL Health–Jewish Hospital and the Univ...
Ultrasound-guided transfemoral transcatheter aortic valve implantation (TAVI...
Randomised trials are needed to evaluate the safety and effectiveness of tra...
Abbott has announced that the US Food and Drug Administration (FDA) has appr...
OpSens has announced that it has received Health Canada approval to commence the...
Following the release of the European Society of Hypertension’s (ESH’s) upda...
One-year data from preclinical trials of Xeltis restorative coronary artery bypa...
The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking ...
European Society of Hypertension (ESH), the leading hypertension (HTN) society i...
Peijia Medical has announced the initiation of its multicentre clinical tria...
Christoph Naber (Essen, Germany) talks to Cardiovascular News about his career i...
Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potentia...
CytoSorbents has filed an investigational device exemption (IDE) application to ...
STENTiT, a medical device company bringing a novel class of regenerative end...
When a modified surgical technique was used to gently remove sections of leg vei...
Concept Medical has announced the enrolment of the thousandth patient in ABILITY...
“During a heart attack time is myocardium,” says Annapoorna Kini (New York, ...
Adults younger than 45 years who reported recently using cannabis were two times...
August’s top 10 features a stark warning over representation of women in clinica...
HeartFlow has announced that physicians at Erasmus MC Hospital (Rotterdam, T...
Findings of the STOPDAPT-2 ACS trial presented during a hot line session at ...
Abbott has announced late-breaking data from the Amulet LAA Occluder IDE tri...
Work stress, sleep disorders, and fatigue—which are regarded as non-traditional ...
Marco Valgimigli (Lugano, Switzerland) talks to Cardiovascular News abo...
Adding systematic fractional flow reserve (FFR) assessment to coronary angio...
MedAlliance today announced first patient enrolment in the coronary randomised c...
Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients...
Edoxaban is noninferior to warfarin and its analogues for adverse clinical e...
One month of dual antiplatelet therapy (DAPT) following stent implantation i...
The world’s first feasibility study has found that drones can be used to deliver...
The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatm...
Adherence to lifestyle advice and medications could add seven healthy years of l...
CARMAT has announced the second centre implanting its bioprosthetic artificial h...
Medtronic has announced US Food and Drug Administration (FDA) approval of its ne...
Young heart attack victims are more likely to be smokers, obese, and have hi...
Cardiac Dimensions has announced the launch of the US pivotal study the EMPO...
Readmissions within 30 days are more common following urgent, rather than el...
In this issue:
Meta analysis draws out debate on coronary revascularisation...
In this issue:
Meta analysis draws out debate on coronary revascularisation...
Translumina has announced the publication of 10-year clinical outcome data for i...
Ultromics, a developer of AI enabled cardiovascular imaging solutions, has annou...
The US Food and Drug Administration (FDA) has granted breakthrough device de...
Biotronik has announced the results from a new study published in EP Europace th...
Sinomed has announced the first commercial implantation of the HT Supreme dr...
Physicians at Mount Sinai Health System (New York, USA) have developed a mobile ...
CytoSorbents has been granted a second breakthrough device designation for its D...
Abbott has announced that the US Food and Drug Administration (FDA) has app...
Occlutech Holding has announced the conditional US Food and Drug Administration ...
An imaging technology developed using artificial intelligence (AI) could become ...
Caption Health has announced that the Centers for Medicare and Medicaid Serv...
Women remain underrepresented in cardiovascular clinical trials despite initiati...
RealView Imaging has announced that it has received US Food and Drug Administrat...
With the COVID-19 pandemic having switched virtually all of the major meetin...
Our top 10 stories of July 2021, including: A milestone for coronary balloon ang...
The largest analysis of its kind to look at the impact of COVID-19 on adult ...
Abbott has announced that it has received US Food and Drug Administration (FDA) ...
Edwards Lifesciences has announced that it has received regulatory approval from...
The USA saw a 10% decline in percutaneous coronary intervention (PCI) proced...
Angel Medical Systems (AngelMed) has announced the first commercial implantation...
An analysis of the rates rehospitalisation and mortality in heart failure pa...
Medtronic has announced the launch of the Prevail drug coated balloon (DCB) cath...
This advertorial is sponsored by Medtronic
The first case using the Preva...
CathWorks has announced that the Japanese Ministry of Health, Labour and Wel...
Among patients undergoing mitral valve surgery after failed transcatheter ed...
Clinical and economic results from the 3M TAVR economic study have been pres...
Patients with bicuspid aortic stenosis may benefit as much from transcathete...
Two-year results from the PINNACLE FLX clinical trial assessing the safety and e...
MedAlliance has launched Origin SC and Origin NC, two high performance balloons ...
Ancora Heart has closed US$80 million in equity financing, with the funds to...
HeartFlow has entered into a definitive business combination agreement with ...
Carmat has announced the first implantation of its bioprosthetic artificial hear...
Patients undergoing permanent pacemaker implantation after surgical aortic v...
atHeart Medical has announced the successful treatment of the first five pat...
East End Medical has announced it has received US Food and Drug Administrati...
Global action is needed to improve clinician wellbeing, according to four leadin...
Xeltis has announced that it has started a pivotal trial for a synthetic restora...
The American Heart Association (AHA) has published a scientific statement ch...
Our top 10 stories of June 2021, including: Analysis of the data for transcathet...
CytoSorbents has received approval for its investigational device exemption (IDE...
Carta Healthcare has announced that it has been certified as a National Cardiova...
Sinomed has announced a partnership with the National University of Ireland ...
Assessment of patients by both interventional cardiologists and cardiac surg...
Royal Philips has announced the first procedure using its real-time 3D intracard...
Abbott has today announced that its Xience family of stents has received US ...
Clinical practice guidance released today outline recommendations for reduci...
Electroducer has announced that it has raised €3 million (US$3.65M) from private...
The risk of heart damage from COVID-19 infection is far greater than that from r...
Heart attacks during the COVID-19 pandemic were more likely to result in hea...
Angel Medical Systems (AngelMed) has announced US Food and Drug Administration (...
Nearly one in eight coronary artery bypass graft (CABG) patients are readmit...
The first end-to-end remotely guided transcatheter aortic valve implantation...
Abbott has received Breakthrough Device designation from the US Food and Dru...
Royal Philips has announced the official start of the DEFINE GPS study, with...
After speaking with experts, reviewing current evidence, surveying people living...
Data captured in the National Cardiovascular Data Registry (NCDR) is similar...
An investigation into the impact of postoperative complications on long-term qua...
Cindy Grines is an interventional cardiologist and chief scientific officer of N...
In patients with acute coronary syndrome treated with percutaneous coronary ...
The number of people dying from cardiovascular disease (CVD) in Asia is increasi...
CorWave has announced that it has successfully completed the first 90-day precli...
Circulation the flagship journal of the American Heart Association (AHA) has pub...
Shockwave Medical has announced today that the Centers for Medicare & Medica...
A study looking at the timing of coronary artery bypass grafting (CABG) after th...
Pivotal trials of transcatheter aortic valve implantation (TAVI) in low-risk...
Neurescue has announced that the US Food and Drug Administration (FDA) has grant...
A new physiological measurement of heart function could improve survival for...
Early experience with the Evoque (Edwards Lifesciences) tricuspid valve replacem...
GE Healthcare is collaborating with the American College of Cardiology (ACC) thr...
Medtronic is stopping the distribution and sale of the Medtronic HVAD system...
This advertorial is sponsored by Sinomed
As newer-generation drug-eluting...
Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about th...
John Forrest (New Haven, USA) sits down with Cardiovascular News to talk ab...
Our top 10 stories of May 2021, including highlights from both EuroPCR 2021 (18–...
There does not appear to be a relationship between operator and patient gender a...
Siemens Healthineers has announced that it has received CE Mark for the AcuNav V...
LivaNova has successfully completed the initial closing of the divestiture o...
Women who experience acute aortic dissection are older, have more advanced d...
Abiomed has acquired preCARDIA, developer of a proprietary catheter and controll...
Sinomed has announced results from the HT Supreme healing-targeted drug-elut...
There is an increasing understanding of the need for tailored strategies when tr...
A call for greater investment in surgical facilities in the UK in the wake of th...
Interventional cardiologists from across the globe are joining forces for a ...
Eliano Navarese (Bydgoszcz, Poland) talks to Cardiovascular News about a la...
This advertorial is sponsored by Shockwave Medical.
Severe coronary artery ca...
The European Union (EU) Medical Devices Regulation (MDR) takes effect from today...
Foldax has announced the successful first-in-human use of its biopolymer Tria he...
Procyrion has announced the treatment of the first patients in the pilot trial t...
Ajay Kirtane (New York, USA) talks to Cardiovascular News about the RADIANC...
Investigation of the use of an ultra-thin strut biopolymer sirolimus-eluting...
This advertorial is sponsored by Boston Scientific
In recent years, trans...
OrbusNeich and P&F Products & Features, under the joint partnership Orbu...
Results of an observational study using optical coherence tomography (OCT) t...
One-year results of the FUTURE-II study—a randomised trial comparing a thin-...
A meta-analysis of randomised trials comparing a strategy of revascularisation p...
Clopidogrel monotherapy produced better outcomes than aspirin for the long-t...
HeartFlow has announced new data which indicate that the information provide...
Rivaroxaban (Xarelto, Bayer/Janssen), in addition to low-dose aspirin, shoul...
Medtronic today announced new clinical data from the Global SYMPLICITY regis...
Complete two-year follow-up data from the Evolut Low Risk trial, presented d...
Long-term follow-up data from the BIOSOLVE-IV registry, presented at the Eur...
This advertorial is sponsored by PIE Medical
Findings of the multicentre ...
Data presented at hotline and late-breaking trial sessions at the EuroPCR 20...
Royal Philips has announced the European availability of new innovations in its ...
ZOLL Medical Corporation has announced that the US Food and Drug Administrat...
Abbott has announced it has received CE mark for its latest-generation transcath...
Among patients with suspected acute coronary syndrome (ACS), the use of a hi...
The proportion of cardiologists reporting burnout has nearly doubled during ...
ST-elevation Myocardial Infarction (STEMI) patients with multi-vessel diseas...
Switching from ticagrelor to clopidogrel dual antiplatelet therapy (DAPT) af...
Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston...
Apixaban was not superior to standard of care following transcatheter aortic...
Patients with an elevated risk of stroke due to arrhythmia or atrial fibrillatio...
CeloNova BioSciences that its COBRA PzF nanocoated coronary stent (NCS) achi...
Royal Philips has announced the integration of its Interventional Hemodynamic sy...
This advertorial is sponsored by Pi-Cardia
As more transcatheter aortic valve...
This advertorial is sponsored by Osprey Medical
There is a growing recognitio...
Discrimination and harassment are a common experience among those working in car...
In this issue:
Hostile environment: How cardiologists feel about discrimina...
In this issue:
Hostile environment: How cardiologists feel about disc...
Research presented at the American Association for Thoracic Surgery 101st Annual...
Fewer than half (48%) of patients undergoing percutaneous coronary intervent...
A significant proportion of cardiology trainees are uncomfortable with using...
Boston Scientific has announced it has initiated the AGENT IDE trial for the Age...
Mild COVID-19 infection is unlikely to cause lasting damage to the structure or ...
Abbott has announced a new trial focused on improving the treatment for people s...
Our top 10 stories of April 2021, including: highlights from the Society for Car...
ST-elevation myocardial infarction (STEMI) patients received percutaneous corona...
Timothy D Henry (The Christ Hospital Medical, Cincinnati, USA) has assumed t...
Patients suffering from severe mitral regurgitation should be carefully screened...
Medtronic has announced that it has received the CE mark for the Evolut PRO+...
Patients studied in the ISCHEMIA trial, the largest trial to date to compare...
Robotic-assisted percutaneous coronary intervention (PCI) using the second-g...
Analysis of the prospective Fuwai PCI Registry using selection criteria from the...
The Society for Cardiovascular Angiography and Interventions (SCAI) has released...
Two research papers presented at the Society for Cardiovascular Angiography ...
Medtronic has announced results from an interim analysis of the first 171 pa...
Patients hospitalised with COVID-19 may be at risk of developing heart failu...
Phoenix Cardiac Devices has announced that it has received CE mark for its Basal...
CytoSorbents has announced that the US Food and Drug Administration (FDA) has gr...
Initial findings from the North American Cardiovascular COVID-19 Myocardial ...
Abiomed has announced that the first patient has been enrolled in PROTECT IV...
Researchers from King's College London (London, UK) have created 3D replicas of ...
A retrospective observational study of patients undergoing cardiac surgery in th...
The work of the Cardiothoracic Surgical Trials Network (CTSN) in mobilising reso...
Acutus Medical has announced US Food and Drug Administration (FDA) clearance of ...
The first procedure has been completed in SMART (Small Annuli Randomized to ...
Abbott has received CE mark for its next-generation TriClip transcatheter tricus...
Our top 10 stories of March 2021, including: highlights from CRT 2021; convergin...
More patients, particularly those with medical risk factors or from underser...
With recent data pointing to a shift towards more transcatheter aortic valve imp...
Abbott has announced that its Xience stent has received CE mark in Europe fo...
Dipti Itchhaporia has today begun her term as president of the American Coll...
ClearFlow has announced clinical trial results published in the Journal of Cardi...
More than a third of female cardiologists polled in a UK survey on discriminatio...
Patients aged over 65 years were more likely than their younger counterparts to ...
Matheen Khuddus (director of Cardiovascular Research, The Cardiac & Vascular...
B Braun Interventional Systems has announced a collaboration with Infraredx to a...
Alvimedica has announced CE mark approval of Fluydo NC, its PTCA non-compliant b...
Medtronic has received US Food and Drug Administration (FDA) approval for its Ha...
Social media has become an important platform for promoting research within the ...
Endotronix has announced the 100th global implant of the Cordella pulmonary ...
Men with stable coronary artery disease who receive Viagra due to impotence ...
Shockwave Medical has announced that the company has signed an agreement to form...
Bristol Myers Squibb has announced that the US Food and Drug Administration (FDA...
Speaking to Cardiovascular News, Georg Nickenig (Bonn, Germany) details the...
Stephan Achenbach is professor of medicine at the University of Erlangen, Erlang...
Three-year results from the COMPARE-ABSORB trial, presented during a late-br...
Three-year clinical outcomes from the Recre8 trial, a multicentre study comparin...
Lab-created heart valves implanted in young lambs were capable of growth wit...
Imbio has received US Food and Drug Administration (FDA) 510(k) clearance for it...
Cardiovascular Systems has announced that the first patients in the USA have bee...
CytoSorbents has announced the filing of an investigational device exemption (ID...
Elixir Medical has today announced commencement of the INFINITY-SWEDEHEART rando...
Ahmed Bendary (Benha University, Benha, Egypt) details the CardioRisk projec...
Two-year follow-up data the BIOSTEMI trial, presented during a late-breaking...
Thomas Pilgrim (Bern, Switerland) details two-year results from the BIOSTEMI r...
Clinical outcomes up to one year after transcatheter aortic valve implantati...
Five-year follow-up results from the Gore REDUCE study, assessing the Gore C...
The American College of Cardiology (ACC) has announced a number of the late-brea...
Registry data charting the use of direct oral anticoagulants (DOACs) in pati...
Data from an international registry of patients undergoing a procedure known...
Our top 10 stories of February 2021, including: the relationship between TAVI vo...
Following consultation with its notified body, MEDCERT GmbH, Abiomed is introduc...
ControlRad has announced US Food and Drug Administration (FDA) 510(k) cleara...
Favourable rates of ischaemic outcomes were observed among selected high ble...
A global collaboration between international heart failure bodies seeks to stand...
MedAlliance has been awarded breakthrough status for Selution SLR, its sustained...
Innovative Cardiovascular Solutions (ICS) has announced the success of its f...
Vascular Grafts Solutions has announced receipt of marketing clearance from the ...
Two-year outcomes of the PARTNER 3 clinical trial, in which low surgical ris...
An analysis of antiplatelet therapies used during percutaneous coronary inte...
A secondary analysis of the COAPT trial, which sought to account for differe...
Elucid, a developer of AI software to enable cardiovascular disease detection, h...
Inovise Medical has announced that the US Food and Drug Administration (FDA)...
Occlutech has announced the completion of patient enrolment in its pilot study t...
A sub-analysis of the DISRUPT CAD III clinical trial, investigating use of S...
After Shockwave Medical announced that its intravascular lithotripsy (IVL) techn...
Terumo Corporation has signed a definitive agreement to acquire all assets of He...
The American College of Cardiology (ACC) has announced that its 70th annual scie...
Urgent action is needed to address the growing burden of heart failure and t...
A sub-analysis of the Recre8 trial, assessing patients at high bleeding risk...
Caption Health has announced the publication of a study in JAMA Cardiology a...
OpSens has received CE mark approval for the OptoWire III, the latest generation...
Around 50% of patients who have been hospitalised with severe COVID-19 and h...
With the COVID-19 pandemic creating new barriers to the accessibility of hea...
Teleflex has announced the completion of patient enrolment in a clinical study e...
Shockwave Medical has announced that its intravascular lithotripsy (IVL) technol...
Dropping aspirin shortly after percutaneous coronary intervention (PCI) is a...
A study detailing early experience of the Pascal transcatheter valve system ...
Off-pump coronary artery bypass grafting (OPCABG) is a safe and effective option...
The number of patients with heart failure worldwide nearly doubled from 33.5 mil...
Robotic-assisted treatment is on the cusp of achieving its full potential, says ...
Updated recommendations on the optimal antithrombotic treatment of patients with...
The authors of a systematic review and meta-analysis, looking at the effect ...
MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its lar...
iVascular has announced that its Angiolite drug-eluting stent (DES) is available...
Royal Philips has announced that it has completed the acquisition of BioTelemetr...
Puzzle Medical has announced that the US Food and Drug Administration (FDA) has ...
Cardiovascular Systems has announced that the first patient in Europe has be...
COVID-19 patients who suffer a cardiac arrest either in or out of hospital are f...
Drug-eluting stent implantation guided by intravascular ultrasound (IVUS) is ass...
A study published in the Journal of Cardiac Surgery, detailing 18 out of a group...
Cardiovascular Systems (CSI) has partnered with Chansu Vascular Technologies...
Minimally invasive aortic valve replacement (miAVR) in select patients with ...
Forge Medical has announced the publication of results of an investigator-initia...
The risk of burnout among cardiothoracic surgeons has been heightened by the...
Cardiothoracic surgeon Sean C Grondin from the University of Calgary (Calgary, C...
Five-year data from the COMMENCE clinical trial, presented at the 57th annua...
Women are significantly less likely than men to undergo coronary artery bypass g...
The COVID-19 pandemic has caused a substantial decline in overall heart surg...
A study of 356 patients treated with Impella 5.5 with SmartAssist (Abiomed) at 1...
An analysis of data from the ADAPT-DES registry, published in JACC: Cardiovascul...
Ancora Heart has announced enrolment of the first patient in the CORCINCH-HF...
PhaseBio Pharmaceuticals has expanded its pivotal phase 3 REVERSE-IT trial for b...
In this issue:
Long-term registry data show TAVI has overtaken surgical aor...
In this issue:
Long-term registry data show TAVI has overtaken surgical aor...
SIS Medical has announced the publication of the ISAR-CALC—ComparIson of Strateg...
Current scoring systems used to assess the risk of mortality in minimally in...
HeartFlow has announced that National Health Service England (NHSE) and NHS ...
Foldax has today announced publication of a research paper in Advanced NanoB...
Alleviant Medical has announced that the US Food and Drug Administration (FDA) h...
Aktiia has announced that its automated blood pressure monitoring system has...
A patient’s risk of coronary heart disease may be more accurately predicted ...
Analysis of data from English hospitals suggests that there was a sharp decline ...
Tributes have been paid to David Foley, professor of Interventional Cardiology a...
Cardiovascular Systems has received the CE mark for its Diamondback 360 coro...
Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, ...
Abbott has announced that the US Centers for Medicare & Medicaid Service...
Occlutech has announced that the US Food and Drug Administration (FDA) has grant...
Results from the EXTRACT-PE trial, which found that Penumbra’s Indigo aspira...
The British Heart Foundation (BHF) has warned of the potentially dire consequenc...
iVascular has announced that its Angiolite drug-eluting stent (DES) offers a 6mm...
Complete revascularisation is rarely achieved in patients with multivessel c...
Robocath has announced the successful completion of the first remote robotic...
The Foundry today announced the completion of the first-in-human procedure with ...
Inari Medical has announced US Food and Drug Administration (FDA) 510(k) clearan...
Medtronic Canada has received a new expanded indication from Health Canada f...
The American College of Cardiology (ACC) is partnering with BioIntelliSense, a c...
CathWorks reported the completion of a US$30 million Series D financing roun...
Specialists in congenital and adult cardiac and thoracic surgery have called...
The Cardiovascular Research Foundation (CRF) has announced today David J Coh...
Patients with acute heart failure nearly double their risk of dying if they ...
The US Food and Drug Administration (FDA) has cleared the use of EchoGo Pro ...
CorWave has rasied €35 million to fund the next stages of its development. The c...
BioVentrix has announced that heart failure specialist Jerry Estep (Clevelan...
VDYNE has announced today that it has secured a US$21 million Series C financing...
This advertorial is sponsored by Boston Scientific
Results of the SCOPE I...
Jian’an Wang (Heart Center, Zhejiang University, Hangzhou, China) has been named...
Edwards Lifesciences has announced that the first patient has been treated i...
Michael Poon (Lenox Hill Hospital-Northwell Health, New York, USA) discusses the...
Edwards Lifesciences has announced that Health Canada has approved the expan...
Abbott has announced that the US Food and Drug Administration (FDA) has appr...
A subgroup analysis of the ISAR REACT-5—Intracoronary Stenting and Antithromboti...
New joint clinical practice guidelines on the treatment of patients with valvula...
Concept Medical has been granted "Breakthrough Device Designation" from the Cent...
Writing for Cardiovascular News, Harold Dauerman, Rony Lahoud and Newton Phu...
Foldax has announced that the US Food and Drug Administration (FDA) has granted ...
Paying patients are 20% less likely than NHS patients to die or develop majo...
Abiomed has announced that its Impella ECP heart pump has completed the first st...
Genetesis has announced that its flagship product, CardioFlux, has been granted ...
The American College of Cardiology (ACC) will collaborate with Amgen and Ver...
Corindus has announced today global launch of a new set of automated robotic...
Acutus Medical has announced CE mark approval and the European launch of its int...
Global leaders in the field of cardiothoracic surgery will debate the impact of ...
Abbott has announced the global release of its first virtual reality-based train...
Acarix has announces the enrolment of the final patient in the Dan-NICAD II ...
The first international registry of patients undergoing transcatheter mitral int...
Gilbert Tang (New York, USA) talks to Cardiovascular News about the key find...
Pre-existing coronary arterial disease (CAD) was associated with higher in‐hospi...
LivaNova has entered into an agreement with investment firm Gyrus Captial wh...
Cathy Gates has been named as the new CEO of the American College of Cardiol...
Reduced effectiveness of treatment and increased running costs are likely to hav...
Tim Henry (Cincinnati, USA) talks to Cardiovascular News about the initial f...
Please NOTE: This video is ONLY available to watch in selected countries and geo...
Baylis Medical has announced the publication of data demonstrating procedura...
A study published in the Journal of the American College of Cardiology (JACC) ha...
Women face a 20% increased risk of developing heart failure or dying within five...
Vectorious Medical Technologies has announced that the US Food and Drug Administ...
Philips has announced the next generation of its advanced visualisation workspac...
Gore has announced encouraging clinical results from its early feasibility study...
Jörg Hausleiter (Munich, Germany) talks to Cardiovascular News about the o...
Long-term data on the outcomes of surgery after failed transcatheter edge-to...
Data from the EXPAND G4 study, evaluating the performance of the latest gene...
Eight-year findings from the NOTION I trial—the first all-comers trial to ra...
Emerging data supports transcatheter techniques to treat primary mitral regu...
Details of an early feasibility study of transcatheter mitral edge-to-edge r...
Two-year outcomes from the MITRAL trial, presented at PCR Valves e-course (2...
One-year findings from the EXPAND registry, evaluating real-world use of new...
The first randomised trial comparing a course of pre-procedure percutaneous ...
Discussion during the first day of the PCR Valves e-course (22–24 November, ...
University of Leicester and University Hospitals of Leicester NHS Trust (UHL), L...
A study published in ACS Biomaterials Science & Engineering details the deve...
Corvia has announced completion of randomisation in its REDUCE LAP-HF II glo...
Boston Scientific has announced a global recall of all unused inventory of i...
Sinomed has announced the presentation of data from its inter-continental PI...
The volume of transcatheter aortic valve implantation (TAVI) procedures in t...
Atrial fibrillation (AF) was detected up to 10 times more frequently in high...
Among patients who stopped taking statins due to side effects, researchers f...
A one-month treatment of dual anti-platelet therapy (DAPT) is safe and as ef...
The use of ticagrelor was not superior to clopidogrel in the reduction of th...
The primary results from the RIVER Trial—Rivaroxaban for Valvular Heart dise...
A pooled analysis of interventional studies assessing the feasibility, effic...
Append Medical, developer of the Appligator implant-free left atrial appenda...
A pioneer in the field of transcatheter aortic valve implantation (TAVI), Michae...
Heart valve procedures performed by cardiothoracic surgeons with 10 years of exp...
Structural racism is a major cause of poor health and premature death from heart...
Results of the Onyx One Clear study, evaluating the safety and effectiveness...
Abiomed has announced that the first 1,000 patients have been treated with the I...
A significant decline in percutaneous coronary intervention (PCI) procedures...
Payments from device manufacturers to physicians are likely to have a bearing on...
AstraZeneca’s Forxiga (dapagliflozin)—known as Farxiga—has been approved in the ...
The use of ticagrelor in patients with acute coronary syndrome (ACS) undergoing ...
MyoKardia has announced three awardees of the 2020 MyoSeeds research grant progr...
Kevin Croce, director, Chronic Total Occlusion and Complex Percutaneous Coro...
COVID-19 patients with a history of heart failure were associated with a longer ...
Late-breaking science in interventional cardiology is alive and well despite the...
Abiomed has announced the treatment of the first two patients using the Impella ...
Mounting evidence over the safety and efficacy of shorter-term dual antiplat...
Foldax has announced that the US Food and Drug Administration (FDA) has granted ...
The European Society of Cardiology (ESC) has announced that its full portfolio o...
BioCardia has announced the publication of data from the initial open-label roll...
A study published in the Journal of the American College of Cardiology (JACC) ha...
NOTE: This video is ONLY available to watch in selected countries and geographie...
The US Food and Drug Administration (FDA) has granted Abiomed a 510(k) clear...
Tricuspid annular dilatation (TAD) is an independent predictor of all-cause mort...
The American College of Cardiology (ACC) has published an expert consensus decis...
A research programme into understanding the underlying causes of unexplained car...
A meta-analysis of 23 randomised clinical trials comparing percutaneous coro...
Rhian E Davies (University of Washington Medical Center, Seattle, USA) discu...
The Journal of the American College of Cardiology (JACC) has issued a three-part...
Results of the OPTIMIZE IDE study, assessing the Svelte drug-eluting stent (DES)...
Biosensors has announced the award of a CE mark for BioFreedom Ultra drug-coated...
CeloNova BioSciences has announced interim results from the randomised Trial...
Results of the HOST-REDUCE-POLYTECH-ACS, presented at TCT Connect 2020 (14–1...
One-year follow-up results of the randomised SOLVE-TAVI trial showed similar rat...
One-year clinical outcomes from the global EXPAND study, reporting on the use of...
In this issue:
POPular TAVI prompts call for aspirin-only antiplatelet stra...
Shockwave Medical has announced that the coronary Investigational Device Exempti...
In this issue:
POPular TAVI prompts call for aspirin-only antiplatelet stra...
Royal Philips has announced one-year results of the DEFINE PCI study, presented ...
A shorter course of dual antiplatelet therapy (DAPT) after percutaneous coro...
Interventional closure of an iatrogenic atrial septal defect (iASD) driven by tr...
The REFLECT II randomised clinical trial evaluating the safety and efficacy of a...
Findings of the SCOPE II clinical trial, which were presented during a late ...
An interim analysis of the Restore EF Study, presented at TCT Connect 2020 (...
One in five high-risk patients undergoing major non-cardiac surgery will develop...
Cardiovascular Systems has announced the presentation of results from a larg...
Initial findings from the North American COVID-19 ST-Segment Elevation Myoca...
Medtronic has today announced a partnership with The Foundry—a medical device co...
A pilot randomised trial of percutaneous coronary intervention (PCI) of non-flow...
Medtronic has today announced plans to launch a randomised, head-to-head stu...
NuVera Medical has announced positive results from its first-in-human feasib...
LivaNova has announced new data from the Perceval Sutureless Implant Versus Stan...
The president of the European Association For Cardiothoracic Surgeons (EACTS...
“We now live in a world of wires,” commented Tom C Nguyen (chief of cardiac ...
Ahead of the first virtual edition of the Transcatheter Cardiovascular Thera...
Butterfly Network and the American College of Cardiology (ACC) have announced a ...
This article, part of an educational supplement sponsored by Siemens Healthine...
Patients with postoperative atrial fibrillation (AF) after coronary artery b...
AngelMed has announced the first implant of the next-generation AngelMed Guardia...
The European Society of Cardiology (ESC) and the European Association for Ca...
Javier Escaned (Hospital Universitario Clínico San Carlos, Madrid, Spain) discus...
An analysis of the rates and clinical implications of alternative definitions of...
Medtronic has announced that it has received US Food and Drug Administration...
Research has identified 2,085 excess deaths in England and Wales linked to cardi...
Cardiac Dimensions has closed a US$17.5 million series C financing round whi...
Boston Scientific has today announced it has initiated a controlled launch o...
InnovHeart has announced the successful first-in-human implantation of its propr...
Transcatheter aortic valve implantation (TAVI) device selection should be gu...
Over the last decade, the cath lab has transformed. Interventional cardiologists...
V-Wave has closed a Series C financing extension of up to US$98 million, assurin...
Medtronic has received Breakthrough Device Designation status from the US Food a...
After surviving a heart attack, the proportion of patients who experience a ...
Abbott has today announced it has received CE mark approval for its fourth-gener...
A study of US Medicare patients undergoing percutaneous coronary interventio...
The Cardiovascular Research Foundation (CRF) has announced that over 30 late-bre...
J Dawn Abbott is the director of interventional cardiology and an associate prof...
Aspirin-free prasugrel monotherapy following successful everolimus-eluting stent...
VitalConnect has announced the commencement of the TELESTAR-TAVR clinical st...
Healthcare professionals should become more familiar with medications that c...
Cardiac magnetic resonance imaging (MRI) is effective in identifying inflamm...
Survey results published to mark Heart Valve Disease Awareness Week show that ol...
Multiple studies have shown that fractional flow reserve (FFR) is a valuable mod...
Results of the TIDES-ACS randomised controlled trial, confirming the superio...
Medtronic has announced US Food and Drug Administration (FDA) approval of an ea...
Researchers from the University of Minnesota, with support from Medtronic, have ...
Cardiac Dimensions has announced that Australia’s Therapeutic Goods Administrati...
Fujifilm Sonosite has received 510(k) clearance from the US Food & Drug Admi...
Japan and the USA have seen an increase in percutaneous coronary intervention (P...
Concept Medical has announced the enrolment of the first patient in the TRANSFOR...
CryoLife has announced the acquisition of Ascyrus Medical, developer of the Ascy...
The American College of Cardiology (ACC) has announced that its 70th Annual Scie...
BioVentrix has announced the resumption of cases in the pivotal ALIVE Trial stud...
An invasive approach involving either percutaneous coronary intervention (PC...
According to findings of the POPular CABG trial, the addition of ticagrelor ...
Royal Philips has announced the next-generation of its Azurion image-guided ...
Miracor Medical has announced the closing of a €24 million series-E round of...
Atrial fibrillation (AF) is associated with long-term mortality in patients ...
The POPular TAVI trial has challenged current recommendations on antiplatele...
Mavacamten (MyoKardia) improves heart function and symptoms in patients with...
Transcatheter mitral valve replacement (TMVR) with the Tendyne device (Abbott) r...
The European Society of Cardiology (ESC) has issued new guidelines, published on...
Empagliflozin reduces the risk of cardiovascular death or hospitalisation for he...
Medtronic has announced that the US Food and Drug Administration (FDA) has a...
Meta analysis puts spotlight on optimal DAPT duration
Cardiologists warn ...
Meta analysis puts spotlight on optimal DAPT duration
Cardiologists warn ...
In this educational supplement, sponsored by Siemens Healthineers, Cardiovas...
The inaugural CX Aortic Vienna meeting will be livestreamed 8–11 September 2020 ...
Philips announced today the latest addition to its portfolio of dedicated cardio...
Guidelines for reducing the risk of stroke in patients undergoing heart surg...
The Heart Rhythm Society has announced the publication of the inaugural issue of...
The risk of in-hospital death and in-hospital heart failure increased for ST-ele...
A study comparing recommendations from a heart team versus those of an inter...
Representation of women leading heart failure research remains lim...
Transcatheter tricuspid valve replacement in the setting of trans-tricuspid ...
Royal Philips has announced the introduction of OmniWire, a solid core pressure ...
Ahead of the 2020 European Society of Cardiology (ESC) Congress, taking plac...
COVID-19 patients with cardiovascular comorbidities or risk factors are more lik...
Translumina has announced the publication of 10-year follow-up data on its d...
With whole sections of society migrating online during the COVID-19 pandemic...
Mental stress and anger may have clinical implications for patients with heart f...
Biosensors announced today the enrolment of the first patient in REFORM—a prospe...
A US survey released by patient advocacy group Heart-Valve-Surgery.com, with sup...
InnovHeart—developer of novel transcatheter mitral valve replacement (TMVR) syst...
The Journal of the American Heart Association (JAHA) has retracted a paper publi...
Thirty-day clinical outcomes from the FORWARD PRO international study of the...
CardioMech, developer of a transfemoral, transseptally delivered mitral valve re...
A meta-analysis of 24 randomised controlled trials assessing dual antiplatel...
Eko has announced a collaboration with AstraZeneca to accelerate the development...
The US Food and Drug Administration (FDA) has issued an emergency use author...
In this educational supplement, sponsored by Boston Scientific, Cardiovascular N...
As interventional cardiology continues to grow with higher risk patients and...
A German study of recently-recovered COVID-19 patients examined using magnetic r...
A three-year, investigator-led, prospective study of Japanese patients who r...
One-year outcomes of mitral valve-in-valve replacement using the Sapien 3 (E...
Keystone Heart has announced completion of the first worldwide commercial ca...
Use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat first-time heart ...
The American College of Cardiology (ACC) is expanding its JACC family of peer-re...
The US Food and Drug Administration (FDA) has approved one-way digital data ...
Aortic valve replacement, using either transcatheter aortic valve implantati...
Caption Health, a developer of medical artificial intelligence (AI) technolo...
MyoKardia has announced that the US Food and Drug Administration (FDA) has grant...
Digital health and artificial intelligence (AI) company Eko has been awarded a U...
Genetic testing and counselling for inherited cardiovascular diseases may he...
Findings of a US investigation of clinician race and gender bias in decision...
Scitech has announced that the Inspiron coronary sirolimus eluting stent has rec...
Boston Scientific has received US Food and Drug Administration (FDA) approva...
LifeSignals Group has announced that it has received US Food and Drug Administra...
Azeem Latib (New York, USA) spoke to Cardiovascular News about a sub-analysi...
Philipp Lurz (Leipzig, Germany) speaks to Cardiovascular News abou...
LivaNova has announced that the advanced Perceval Plus sutureless surgical aorti...
Women taking beta blockers for hypertension with no prior history of cardiovascu...
A rise in the number of out-of-hospital cardiac arrests (OHCAs) correlated with ...
Edwards Lifesciences has announced approval from the US Food and Drug Admini...
The American Heart Association (AHA) has announced that its 2020 Scientific Sess...
Around half of COVID-19 patients who received an echocardiogram in-hospital show...
Revamp Medical has announced that the US Food and Drug Administration (FDA) has ...
ACIST Medical Systems has announced the global launch of its ACIST Navvus II Rap...
Venus Medtech has announced a collaboration to bring Pi-Cardia's Leaflex tec...
The European Association of Percutaneous Cardiovascular Interventions (EAPCI...
Janarthanan Sathanathan (Center for Heart Valve Innovation, St Paul’s Hospit...
Paragonix Technologies presented new clinical data at the American Transplant Co...
MedAlliance has announced enrollment of the first patient in its study of Se...
Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News abou...
Black patients who undergo percutaneous coronary intervention (PCI) are at an ...
Ancora Heart has been given US Food and Drug Administration (FDA) approval o...
The American Heart Association (AHA) has named Mitchell SV Elkind as preside...
Using an Impella device is contraindicated in patients with severe aortic st...
NuVera Medical has announced the initiation of the company's first-in-human ...
US national hospital- and surgeon-level inverse volume–outcome associations ...
Patients who have trouble sleeping after heart bypass surgery should go for a ...
US Food and Drug Administration (FDA) Investigational Device Exemption (IDE)...
Mid-term data continue to show non-inferiority of resting instantaneous wave...
A subanalysis of the Onyx One study found that cardiac death was significant...
Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) d...
MedAlliance has been awarded CE mark for the Selution SLR 014 percutaneous trans...
BioCardia has announced that it has resumed cases in the CardiAMP Heart Fail...
The feasibility, safety, and efficiency of transcatheter aortic valve implan...
According to a press release, one-year total population clinical outcome dat...
The FABOLUS FASTER trial, which was presented at PCR e-Course 2020 and simul...
Felice Gragnano (Inselspital, Bern University Hospital, Bern, Switzerland) o...
Left atrial appendage occlusion (LAAO) improves clinical outcomes including ...
Sripal Bangalore (New York University Grossman School of Medicine, New York,...
One-year results from the TRILUMINATE study show that TriClip (Abbott) trans...
Clinical and imaging results at 12 months for the DynamX Novolimus-Eluting C...
A systematic two-stent approach in complex coronary bifurcation lesions is a...
Patients who crossed over from the sham control arm of the RADIANCE-HTN SOLO...
Full one-year follow-up from the Evolut Low Risk trial has upheld earlier findin...
Long-term clinical outcomes, including mortality, following an aortic valve-...
Use of the transseptal Evoque transmitral valve replacement (TMVR) system (E...
A comprehensive evaluation of mitral valve-in-valve (ViV) and valve-in-ring ...
The American College of Cardiology (ACC) and Society for Vascular Surgery (S...
Miracor Medical has announced the award of the CE mark for its latest genera...
Medtronic has been awarded CE mark for the use of the Evolut transcatheter a...
Voice analysis by a smartphone app can identify lung congestion in heart failure...
Proximo Medical has announced a partnership with digital health company Coal...
Abiomed has launched a virtual physician education programme, CAMP PCI (Coro...
Trainee interventional cardiologists have raised concerns that reductions in...
Telemedicine has come into its own during the pandemic. Sameer Mehta details...
Blue Sail Medical has completed the acquisition of Swiss based company NVT A...
MicroPort has been given CE approval for its PathBuilder Steerable Introduce...
The British Heart Foundation (BHF) is calling on the Government and the NHS ...
Abiomed has received investigational device exemption (IDE) from the US Food...
Biosensors International Group has announced the appointment of Keith G Oldr...
Collaboration between cardiothoracic and vascular surgeons is key to achievi...
Medtronic has received the CE mark for a one-month dual antiplatelet therapy...
Clinical and echocardiographic outcomes at 30 days and one year were similar...
Mitral and tricuspid valve technologies, aortic valve replacement, and the v...
The American College of Cardiology (ACC) is to host a weekly virtual meeting...
The European Society of Cardiology (ESC) has announced that the HFA Discoveries ...
COVID-19 linked to a near 40% drop in STEMI cases in US cath labs
Survey ...
COVID-19 linked to a near 40% drop in STEMI cases in US cath labs
Survey ...
A Bayesian analysis of EXCEL and other randomised controlled trials comparing co...
LivaNova have presented the first data from the Perceval sutureless implant ...
CeloNova BioSciences has announced that it has successfully completed enrolmen...
The annual Transcatheter Cardiovascular Therapeutics (TCT) meeting has become th...
The Society for Cardiovascular Angiography and Interventions (SCAI) and the ...
According to research published in JACC: Heart Failure, patients with heart ...
A press release reports that the Society of Cardiovascular Computed Tomograp...
According to a survey published in the Journal of Occupational and Environme...
In JACC: Heart Failure, Mathias Orban (Medizinische Klinik und Poliklinik I,...
Several studies have suggested that, across all countries, COVID-19 mortalit...
